Trastuzumab Administered Concurrently or Sequentially to Anthracycline-containing Adjuvant Regimen for Breast Cancer

NCT01413828 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

201

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: concurrent
DRUG: sequential

Sponsor

Peking Union Medical College Hospital